1. Home
  2. PBM vs CERO Comparison

PBM vs CERO Comparison

Compare PBM & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • CERO
  • Stock Information
  • Founded
  • PBM 1994
  • CERO 2017
  • Country
  • PBM Canada
  • CERO United States
  • Employees
  • PBM N/A
  • CERO N/A
  • Industry
  • PBM
  • CERO
  • Sector
  • PBM
  • CERO
  • Exchange
  • PBM NYSE
  • CERO Nasdaq
  • Market Cap
  • PBM 5.3M
  • CERO 8.4M
  • IPO Year
  • PBM N/A
  • CERO N/A
  • Fundamental
  • Price
  • PBM $1.37
  • CERO $1.92
  • Analyst Decision
  • PBM
  • CERO
  • Analyst Count
  • PBM 0
  • CERO 0
  • Target Price
  • PBM N/A
  • CERO N/A
  • AVG Volume (30 Days)
  • PBM 526.0K
  • CERO 787.1K
  • Earning Date
  • PBM 02-02-2025
  • CERO 02-20-2025
  • Dividend Yield
  • PBM N/A
  • CERO N/A
  • EPS Growth
  • PBM N/A
  • CERO N/A
  • EPS
  • PBM N/A
  • CERO N/A
  • Revenue
  • PBM N/A
  • CERO N/A
  • Revenue This Year
  • PBM N/A
  • CERO N/A
  • Revenue Next Year
  • PBM N/A
  • CERO N/A
  • P/E Ratio
  • PBM N/A
  • CERO N/A
  • Revenue Growth
  • PBM N/A
  • CERO N/A
  • 52 Week Low
  • PBM $1.21
  • CERO $1.76
  • 52 Week High
  • PBM $323.25
  • CERO $1,238.00
  • Technical
  • Relative Strength Index (RSI)
  • PBM 37.76
  • CERO 34.43
  • Support Level
  • PBM $1.21
  • CERO $1.76
  • Resistance Level
  • PBM $1.59
  • CERO $3.18
  • Average True Range (ATR)
  • PBM 0.24
  • CERO 0.38
  • MACD
  • PBM 0.03
  • CERO 0.30
  • Stochastic Oscillator
  • PBM 17.53
  • CERO 19.72

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: